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deaths as a result of any procedures.
Conclusions: A transradial artery approach for balloon
angioplasty maturation of proximal arm fistulae provides at
least equivalent success rates to a standard direct fistula
approach with minimal complications.
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The Use of Subclavian-Atrial Bypass for the Treatment of
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Brown, Frank Baciewicz, Jeffrey J. Rubin. Wayne State
University School of Medicine, Detroit, MI
Objectives: Hemodialysis patients may encounter severe
complications as a result of central venous hypertension. The
increasing expertise with endovascular skills offers alternative
therapeutic options, but repeat procedures are common, and
when these fail, a more definitive intervention is necessary
Methods: We reviewed the records of 3 consecutive
patients presenting with massive upper extremity edema
and functioning but threatened dialysis grafts. All patients
had central venous hypertension due to subclavian or supe-
rior vena cava obstruction. These patients were evaluated
for either endovascular or open surgical treatment
Results: No patient was found to be suitable for an
endovascular approach. All 3 patients underwent subclavian-
atrial bypass with externally supported PTFE grafts via supra-
clavicular and mini-sternotomy incisions. All 3 patients were
discharged homewithin 5 days with no postoperative compli-
cations and with significant improvement in their edema. All
of the threatened grafts continue to function at 6 months, 1
year, and 3 years. One patient developed a late steal syndrome
successfully treated by a DRIL procedure
Conclusions: A Subclavian-atrial bypass appears to be a
viable treatment alternative in patients presenting with threat-
ened dialysis grafts and symptomatic upper extremity edema
secondary to central venous hypertension
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Screening for Carotid & Renal Stenosis in Patients
Undergoing Tesio Catheter Placement
Lin Roy, Anil Hingorani, Natalie Marks, Enrico Ascher,
Alexsander Shiferson, Kapil Gopal, Daniel Jung, Theresa
Jacob. Division of Vascular Services, Maimonides Medical
Center, Brooklyn, NYObjectives: An earlier report demonstrated that if the
prevalence of significant carotid disease to be greater than
4.5%, screeningmay be cost-effective.Many factors associated
with carotid artherosclerosis are shared with those of chronic
renal disease, and those patients who have severe renal artery
disease may eventually require Tesio catheter placement.
Therefore, we postulate performing carotid/renal duplex
scans in this high-risk population may be of benefit.
Methods: Between July 2005 and August 2009, 641
patients underwent tesio catheter placement. Of these, 136
patients underwent carotid duplexes perioperatively.
Results: 13 patients (9.6%) had60% stenosis, 8 patients
(5.9%) had 70-99% stenosis, and 5 patients (3.7%) had prior
CEA procedure, eachmutually exclusive. Sex was not a signif-
icant factor in the outcome of the carotid duplex scans. Of the
109 patients who underwent renal artery duplex, renal artery
stenosis was noted in 4.9% of the patients and 2 AAA’s were
noted.
Conclusions: Our results indicates a significant preva-
lence of carotid and renal artery stenosis for patients who will
also receive Tesio catheter placement, espescially for those
with history of coronary artery disease and60 years of age.
 60 % 50-70% 70-99% s/p CEA
no DM 10.9% 18.8% 6.3% 1.6%
DM 8.3% 22.2% 5.6% 5.6%
no CAD 3.4% 8.6% 3.4% 0
CAD 14.1% 29.5% 7.7% 6.4%
p value .042 .0028 .467 .071
no HTN 0 20% 0 10%
HTN 8.7% 30.2% 6.3% 3.2%
DM & CAD 12.5% 30% 7.5% 10%
60 y.o. 0 7.1% 0 0
61-80 y.o. 13.2% 27.9% 5.9% 2.9%
81 y.o. 10% 17.5% 10% 7.5%
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disclose; T. Jacob: Nothing to disclose; D. Jung: Nothing
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Objectives: Arteriovenous fistulae (AVFs) are the pre-
ferred dialysis vascular access. Over 50% of AVFs are unsuit-
able for dialysis (”maturation failure”) at 5 months, primar-
ily due to peri-anastomotic stenosis. The objective of the
study was to evaluate the technical feasibility, safety, and
efficacy of a novel anastomotic device for the creation of
arteriovenous fistula (AVF) for hemodialysis.
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Volume 51, Number 11S Abstracts 45SMethods: Ten end-to-side arteriovenous fistulas were
created with a novel anastomotic device (Optiflow™). The
primary safety endpoint was freedom from serious adverse
events (SAEs) and unanticipated adverse device events
(UADE) at 42 days. The primary effectiveness end point
was technical success (patent AVF without complications)
at the end of surgery.
Results: Mean age of the patients was 45 / 12.2
years (6 male, 4 female, 1 diabetic, 100% forearm AVFs).
There were no SAEs/UADEs related to the immediate
placement of the Optiflow. One patient had a pseudoaneu-
rysm at 21 days which was not device related. All patients
achieved technical success and 9/10 patients reached the
secondary effectiveness end point (technical success  pri-
mary patency at 42 days). Median venous diameter of the
proximal vein at 42 days was 8.8 mm (7.2-11.5 mm) as
compared to national guidelines of 6 mm.
Conclusions: These data confirm technical feasibility
and safety of the Optiflow™ device and also describe initial
efficacy data. Future studies will focus on a more prolonged
follow-up in a larger number of patients. We believe that
the Optiflow™ device could be an important adjunct for
the quick and successful creation of ”mature” AVFs in the
dialysis population; resulting in reduced costs and an im-
provement in patient care.
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Hemodialysis Fistulae: An Alternative Percutaneous
Approach
Alessandro Smeraldi, Samir Pancholy, Jason Butchko.
Community Medical Center, Scranton, PA
Objectives: Percutaneous angioplasty of non-matured
proximal arm hemodialysis arteriovenous fistulae presents a
unique challenge given the frequently non-arterialized vein
and the awkward working angle. We describe our tech-
nique using a transradial approach.
Methods: In a single center, patients with non-maturing
proximal arm fistulae were included. They were offered per-
cutaneous angioplasty or creation of a new fistula. Patients
choosing percutaneous angioplasty were given the option of a
standard direct fistula approach or a radial artery approach.
These were later categorized as the standard balloon angio-
plasty maturation (BAM) control group and the radial artery
(RABAM) study group. Radial access was achieved with a
micropuncture and glide sheath systems. Saline, heparin, dil-tiazem and nitroglycerinewere injected directly into the artery
upon cannulation. A 5F sheath was used with low profile
0.014-in platform balloons. A near-occlusive band was used
for post-procedural hemostasis.
Results: A total of 32 procedures were attempted in 28
patients. Three patients were excluded from the RABAM
study group due to a small artery, inability to pass a wire safely
and aberrant high brachial artery bifurcation. The final RA-
BAM study group included 14 successfully performed proce-
dures in 11 patients and the control BAM group included 18
procedures in 14 patients. Procedural success was achieved in
all patients. Nomajor complications were noted. One asymp-
tomatic radial artery occlusion was noted.
Conclusions: A transradial artery approach for balloon
angioplasty maturation of proximal arm arteriovenous fis-
tulae is possible and safe.
Author Disclosures: J. Butchko: Nothing to disclose; S.
Pancholy: Nothing to disclose; A. Smeraldi: Nothing to
disclose.
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New York, NY
Objectives: In an effort to create objective grading criteria
for an endovascular training curriculum,we sought to determine
the validity of computer-generated performance criteria com-
pared to objective structured clinical examination.
Methods: Students were enrolled and received training
on the Simbionix angiomentor simulator. Demographics and
survey data were obtained. Students were tested on a retro-
grade iliac stent (IS) and contralateral SFA stent (SS). Students
practiced 3 different iliac stenting procedures and were re-
tested on the initial 2 cases. Assessment was performed using
the Global Endovascular Rating Scale (GERS) and additional
data obtained from the simulator. Data analysis was done
using paired t-tests and Pearson’s correlation.
Results: 36 students completed training. There was
significant improvement post-practice in all the measures in
GERS. Practice on retrograde IS procedures translated to
improved performances on contralateral SS in 41.6% (15/
36) students compared to 94.4% (34/36) on IS proce-
dures. Simulator generated values were improved for total
fluoroscopy time ( 03:04min, p  0.003 for iliac and 
6:56min, p  0.005 for SFA), volume of contrast ( 15.3
and 21.1 mL for iliac&SFA respecively, p  0.01) and
correct stent diameter (p  0.045) but not for ACT level,
residual stenosis and correct placement of stents. Students
with prior endovascular knowledge found the simulator
easier to use (r is 0.36, p  0.05) but this did not affect
